Our group focuses on the development of therapeutic solutions for muscle diseases and FSHD in particular.
London, England
Joined January 2020
- Tweets156
- Following101
- Followers233
- Likes266
I am very happy to share our article on the characterisation of the MCM/FLExDUX4 mice. We highlighted several changes that could be used as markers of therapeutic efficacy and developed a force test that reflects the movements made in everyday life. #FSHD
doi.org/10.3390/ijms25211137…
Virginie Mariot has presented our work on short and long term efficacy of an AAV-shDUX4 in a DUX4 mouse model @FSHDSociety IRC conference in Denver. A lot of very interesting discussions. #FSHD @DNP_ICH
First FSHD UK research team meeting at UCL. When researchers and clinicians meet to pool their strengths to fight FSHD.
Introducing the FSHD UK Research Team
#research #fshd #uk #md #musculardystrophy #clinicaltrials #fshduk
Fantastic talk from Dr Duguez and Dr Rene at the ALS and MND research meeting #ALS @sduguez_lab @UlsterUniMed @ARSLA75
FSHD congress in Milan
Fantastic talks and posters and great people !
#FSHD
@FSHDSociety
It was very nice to see everybody. Fantastic conference !
8
206
ENMC workshop on FSHD. The paper is published. #FSHD @FSHDEurope
nmd-journal.com/article/S096…
Good to know: morning vaccination is more beneficial than evening vaccination.
Last year, a @SciImmunology review highlighted the benefits of morning vaccination compared with afternoon/evening vaccination in humans.
Learn more: scim.ag/2qh #DayOfImmunology
174
Fortitude webinar. Up coming clinical trial for #FSHD
If you missed this week’s FORTITUDE webinar, you can watch the recording on our YouTube channel! Amy Halseth, PhD, and Alissa Peters of @aviditybio discussed the new FORTITUDE clinical trial that will test AOC 1020 in the treatment of #FSHD: bit.ly/3k99bRU #CureFSHD
We are hiring ! A post position (18 months in first instance) is open to develop therapeutic approaches for #FSHD is our lab. Get more information here: ucl.ac.uk/work-at-ucl/search…
Opération 1000 chercheurs dans les écoles. Ravie d'avoir fait une intervention au lycée Français Charles de Gaulle devant les élèves de 2nde. Des moments tjrs très enrichissants. #Telethon2022
Avidity is allowed to begin clinical trial with AOC1020, a siRNA directed against DUX4.
This Post is from an account that no longer exists. Learn more
3
Unconscious bias in science: the Matthew effect. Very interesting.
Peer reviewers read 2 versions of the same paper. One listed a Nobel laureate as the author; the other, a little-known researcher. Guess which one the reviewers liked better. #PRC2022 #mattheweffect #peerreview #academictwitter @ScienceInsider science.org/content/article/…
Beautiful talk of Stephanie Duguez about biomarkers for NMD during the Myology Congress @sduguez_lab #UlsterRare #ALS
Today is the FSHD world day. A picture of top researchers working together to find a cure for FSHD. #FSHD @FSHDSociety
